Stockscreener 앱 받기
3.09
0.99%
0.03
전일 마감가:
$3.06
열려 있는:
$3.08
하루 거래량:
679.27K
Relative Volume:
0.44
시가총액:
$461.41M
수익:
$181.41M
순이익/손실:
$-59.56M
주가수익비율:
-5.9423
EPS:
-0.52
순현금흐름:
$-38.83M
1주 성능:
+1.32%
1개월 성능:
+1.99%
6개월 성능:
+54.51%
1년 성능:
+77.60%
1일 변동 폭
$3.03
$3.12
1주일 범위
$2.82
$3.12
52주 변동 폭
$1.69
$3.64
Xeris Biopharma Holdings Inc Stock (XERS) Company Profile
명칭
Xeris Biopharma Holdings Inc
전화
844-445-5704
주소
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
XERS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| XERS | 3.085 | 461.41M | 181.41M | -59.56M | -38.83M | -0.52 |
| VRTX | 449.95 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 745.89 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.92 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 245.88 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.22 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-21 | 개시 | Jefferies | Buy |
| 2022-04-28 | 개시 | Craig Hallum | Buy |
| 2021-11-17 | 개시 | SVB Leerink | Outperform |
| 2021-10-29 | 개시 | H.C. Wainwright | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2020-02-18 | 개시 | Piper Sandler | Overweight |
| 2018-07-16 | 개시 | Jefferies | Buy |
| 2018-07-16 | 개시 | Leerink Partners | Outperform |
| 2018-07-16 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Xeris Biopharma Holdings Inc 주식(XERS)의 최신 뉴스
Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long - Yahoo Finance
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS): When Will It Breakeven? - Simply Wall St
HC Wainwright Forecasts Reduced Earnings for Xeris Biopharma - Defense World
Wealth Enhancement Advisory Services LLC Invests $35,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
FY2024 EPS Estimate for Xeris Biopharma Raised by Analyst - Defense World
HC Wainwright Forecasts Higher Earnings for Xeris Biopharma - MarketBeat
Xeris Biopharma (NASDAQ:XERS) Rating Lowered to Neutral at Piper Sandler - Defense World
Xeris Biopharma (NASDAQ:XERS) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World
HC Wainwright Forecasts Weaker Earnings for Xeris Biopharma - MarketBeat
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Xeris Biopharma posts record revenue in Q3 2024 - Investing.com India
Earnings call: Xeris Biopharma posts record revenue in Q3 2024 By Investing.com - Investing.com Nigeria
Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highli - GuruFocus.com
Xeris Biopharma Reports Record Third Quarter Revenue - TipRanks
Xeris Biopharma Holdings Inc (XERS) Quarterly 10-Q Report - Quartzy
Xeris raises revenue outlook on strong 3rd-quarter results - Crain's Chicago Business
Xeris Biopharma Reports Third Quarter 2024 Financial Results - BioSpace
Xeris Biopharma (XERS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Xeris Biopharma Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Xeris Biopharma (XERS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Xeris Biopharma Holdings Inc Reports Q3 2024 Revenue of $54.3M, Beating Estimates; EPS Misses at ($0.11) - GuruFocus.com
Xeris Biopharma: Q3 Earnings Snapshot - San Francisco Chronicle
Xeris Biopharma (XERS) to Release Earnings on Friday - Defense World
Xeris Biopharma (XERS) Scheduled to Post Quarterly Earnings on Friday - MarketBeat
Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024 - BioSpace
Xeris Biopharma Holdings: Promising Pipeline And Strategic Partnerships Make It Attractive - Seeking Alpha
SG Americas Securities LLC Raises Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
The Manufacturers Life Insurance Company Buys 5,291 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
The Xeris Biopharma Holdings Inc (XERS) had a good session last reading, didn’t it? - US Post News
Dimensional Fund Advisors LP Sells 6,437 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings Inc (XERS) looking to reclaim success with recent performance - SETE News
Market Recap Check: Xeris Biopharma Holdings Inc (XERS)’s Positive Finish at 2.97, Up/Down 2.06 - The Dwinnex
Xeris Biopharma Holdings Inc [XERS] Insider Activity: An Update for Investors - Knox Daily
Undercovered Dozen: KinderCare Learning, Xeris Biopharma, Generac, Philips + - Seeking Alpha
Xeris Biopharma Holdings Inc [NASDAQ: XERS] Sees Decrease in Stock Value - Knox Daily
Ratio Review: Analyzing Xeris Biopharma Holdings Inc (XERS)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Charting the Course: Xeris Biopharma Holdings Inc’s XERS Stock Prospects - The InvestChronicle
Several Insiders Invested In Xeris Biopharma Holdings Flagging Positive News - Yahoo Finance
Xeris Biopharma: Time For A Reassessment (NASDAQ:XERS) - Seeking Alpha
This trade activity should not be overlooked: Xeris Biopharma Holdings Inc (XERS) - SETE News
A year in review: Xeris Biopharma Holdings Inc (XERS)’s performance in the last year - US Post News
Xeris Biopharma Holdings Inc (XERS) Becoming More Attractive for Investors - Knox Daily
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
XERS Shares Experience Surge in Value - Knox Daily
XTX Topco Ltd Sells 223,267 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
XTX Topco Ltd Cuts Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat
Renaissance Technologies LLC Acquires 342,300 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Perhaps timely catching Xeris Biopharma Holdings Inc (XERS) would be a good idea - SETE News
Understanding the Risks of Investing in Xeris Biopharma Holdings Inc (XERS) - Knox Daily
Rhumbline Advisers Raises Stock Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings Inc (XERS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Xeris Biopharma Holdings Inc 주식 (XERS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schmid John P. | Director |
Aug 09 '24 |
Buy |
2.37 |
4,285 |
10,134 |
20,685 |
| Schmid John P. | Director |
May 10 '24 |
Buy |
1.91 |
5,400 |
10,314 |
16,400 |
| JOHNSON JOHN | Director |
Mar 18 '24 |
Option Exercise |
1.99 |
215,600 |
429,044 |
751,412 |
| Schmid John P. | Director |
Mar 14 '24 |
Buy |
2.16 |
4,500 |
9,720 |
11,000 |
| SHERMAN JEFFREY W | Director |
Nov 27 '23 |
Buy |
1.87 |
5,400 |
10,098 |
5,400 |
1.80%
0.42%
자본화:
|
볼륨(24시간):